Edgewise Therapeutics Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while W.R. Berkley Corporation Common Stock trades at $74.25 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 6.9× Edgewise Therapeutics Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| EWTX | WRB | |
|---|---|---|
Market Cap | $3.94B | $27.30B |
Volume | 810,104 | 2,293,079 |
Sector | Health | Financials |
52-Week High | $48.35 | $78.10 |
52-Week Low | $14.89 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $27.54B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →